Brought to you by 
Pliva acquires Sidmak and Odyssey
10 Jul 2002
Executive Summary
Croatian pharmaceutical company Pliva acquired Sobel's US-based Sidmak Laboratories (generics) along with Sidmak's wholly owned subsidiary Odyssey Pharmaceuticals (branded pharmaceuticals) for a total of Euro231.4mm ($211.9mm)--consisting of $152.9 in cash and $59mm in debt.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Pliva acquires Sidmak and Odyssey
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice